While these options are not yet available as compounded products, they represent the direction the field is heading
Use of GLP1 medications, together with research into new therapeutic applications, is fueling a multimillion-dollar market built around this breakthrough.
White Papers / Tech Papers Tackling Poor Bioavailability with Early Formulation Strategies De-risking oral clinical development with UpperSolv Released By Upperton High failure rates in clinical trials, estimated at up to 90%, remain a major hurdle in drug development, with poor ADME (Absorption, Distribution, Metabolism, and Excretion) properties being one of the leading causes of late-stage attrition
A pre-filled pen with purity 99%
How to use it Preparation & administration The pen solution is ready to use, requiring no additional reconstitution